Specialty Return-to-Work Management
Life|After® is a managed return-to-work program built specifically for cancer-surviving employees — and the students who return to campus carrying the same challenges. We coordinate the specialist support, workplace guidance, and human care each person needs to return successfully — whether that's a desk or a classroom.
Cancer survivors are returning to your workforce. The question is whether they have the support to succeed — and whether you're managing the risk if they don't.
The program
Each returning employee is assigned a dedicated Life|After® care coordinator who coordinates a nationwide network of specialists — tailored to that individual's diagnosis, treatment history, and job requirements.
The care coordinator evaluates the employee's current health status, functional limitations, and workplace demands to build an accurate picture of what support is needed.
A multidisciplinary team — occupational therapists, ergonomists, nutritionists, social workers, and more — assembled around the individual's specific needs.
The care coordinator coordinates the team, tracks progress, and keeps the employer informed at every stage — from first referral through documented case closure.
Who we serve
For CFOs, HR directors, risk managers, and benefits administrators managing a cancer survivor's return — Life|After® provides the structured support your employee needs and the documented process your organization can stand behind.
Cancer-surviving students need more than medical clearance to return to campus. Life|After® provides a structured, coordinated path back to class.
Offer your clients a specialty program that addresses a gap most group benefit packages don't cover — with no complexity added to your book.
The cost of doing nothing
The financial impact extends well beyond disability premiums. Extended absence, lost productivity, accommodation missteps, and failed returns all carry real costs — most of which go untracked and unmanaged.
A sample of what they are managing when they return
And when these go unaddressed — here is what it costs the employer.
The hidden cost
SHRM estimates it costs six to nine months of an employee's salary to replace them. For a tenured teacher, nurse, or administrator earning $60,000, that's $30,000–$45,000 in recruiting and retraining — before accounting for institutional knowledge lost.
A single successful return-to-work case managed through Life|After® typically costs a fraction of that figure — making the program's ROI straightforward even without a single outcome claim.
The productivity gap
Up to 75% of patients experience cognitive changes during treatment, with 35% continuing post-treatment. Fatigue affects up to 50% of survivors beyond treatment end. Without structured support, these impairments go unaddressed — extending the productivity loss indefinitely.
Life|After® bridges the gap between treatment end and genuine return — reducing the duration and depth of that productivity loss with a structured, managed transition.
Life|After® operates on a pay-per-employee model — no retainer, no standing overhead, cost incurred only when a case is active. Survivors are already in your workforce, already navigating this quietly. The need doesn't announce itself. Life|After® is what gives it somewhere to go.
Statistics sourced from CDC/MMWR, the Medical Expenditure Panel Survey, SHRM, and Gallup. Life|After® makes no specific outcome guarantees.
Why Life|After®
Life|After® is built on 20+ years of return-to-work experience serving employers from small businesses to Fortune 20 companies.
Purpose-built for the unique challenges of cancer survivorship — treatment side effects, fatigue, and cognitive changes that persist after remission.
Each case draws on a coordinated multidisciplinary team — deployed remotely and managed centrally, so geography is never a barrier.
Pay-per-employee with no retainer. Employers access the full program only when needed — zero fixed overhead between cases.
Get started
A brief call is all it takes to explore fit — for brokers, HR directors, and institutional buyers alike.